Table of Contents
Journal of Biomarkers
Volume 2013 (2013), Article ID 179864, 9 pages
http://dx.doi.org/10.1155/2013/179864
Review Article

Prostasin: An Epithelial Sodium Channel Regulator

1Department of Biochemistry, ESI Hospital, Basai Darapur, New Delhi 110015, India
2Department of Biochemistry, Chacha Nehru Bal Chikitsalaya, New Delhi 110031, India

Received 31 January 2013; Revised 3 June 2013; Accepted 4 June 2013

Academic Editor: José Luis Martín-Ventura

Copyright © 2013 Shakti Aggarwal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. X. Yu, L. Chao, and J. Chao, “Prostasin is a novel human serine proteinase from seminal fluid. Purification, tissue distribution, and localization in prostate gland,” Journal of Biological Chemistry, vol. 269, no. 29, pp. 18843–18848, 1994. View at Google Scholar · View at Scopus
  2. J. X. Yu, L. Chao, and J. Chao, “Molecular cloning, tissue-specific expression, and cellular localization of human prostasin mRNA,” Journal of Biological Chemistry, vol. 270, no. 22, pp. 13483–13489, 1995. View at Google Scholar · View at Scopus
  3. A. Shipway, H. Danahay, J. A. Williams, D. C. Tully, B. J. Backes, and J. L. Harris, “Biochemical characterization of prostasin, a channel activating protease,” Biochemical and Biophysical Research Communications, vol. 324, no. 2, pp. 953–963, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. G. M. Verghese, M. F. Gutknecht, and G. H. Caughey, “Prostasin regulates epithelial monolayer function: cell-specific Gpld1-mediated secretion and functional role for GPI anchor,” American Journal of Physiology, vol. 291, no. 6, pp. C1258–C1270, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. L.-M. Chen, M. L. Skinner, S. W. Kauffman et al., “Prostasin is a glycosylphosphatidylinositol-anchored active serine protease,” Journal of Biological Chemistry, vol. 276, no. 24, pp. 21434–21442, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. S. H. Donaldson, A. Hirsh, D. C. Li et al., “Regulation of the epithelial sodium channel by serine proteases in human airways,” Journal of Biological Chemistry, vol. 277, no. 10, pp. 8338–8345, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Vuagniaux, V. Vallet, N. F. Jaeger et al., “Activation of the amiloride-sensitive epithelial sodium channel by the serine protease mCAP1 expressed in a mouse cortical collecting duct cell line,” Journal of the American Society of Nephrology, vol. 11, no. 5, pp. 828–834, 2000. View at Google Scholar · View at Scopus
  8. G. H. Caughey, W. W. Raymond, J. L. Blount et al., “Characterization of human γ-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families,” Journal of Immunology, vol. 164, no. 12, pp. 6566–6575, 2000. View at Google Scholar · View at Scopus
  9. S. Netzel-Arnett, J. D. Hooper, R. Szabo et al., “Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer,” Cancer and Metastasis Reviews, vol. 22, no. 2-3, pp. 237–258, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. F. P. Costa, E. L. Batista Jr., A. Zelmanowicz et al., “Prostasin, a potential tumor marker in ovarian cancer—A Pilot Study,” Clinics, vol. 64, no. 7, pp. 641–644, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. C. Mok, J. Chao, S. Skates et al., “Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology,” Journal of the National Cancer Institute, vol. 93, no. 19, pp. 1458–1464, 2001. View at Google Scholar · View at Scopus
  12. V. Vallet, A. Chraibi, H.-P. Gaeggeler, J.-D. Horisberger, and B. C. Rossier, “An epithelial serine protease activates the amiloride-sensitive sodium channel,” Nature, vol. 389, no. 6651, pp. 607–610, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Vallet, C. Pfister, J. Loffing, and B. C. Rossier, “Cell-surface expression of the channel activating protease xCAP-1 is required for activation of ENaC in the Xenopus oocyte,” Journal of the American Society of Nephrology, vol. 13, no. 3, pp. 588–594, 2002. View at Google Scholar · View at Scopus
  14. J. B. Bruns, M. D. Carattino, S. Sheng et al., “Epithelial Na+ channels are fully activated by furin- and prostasin-dependent release of an inhibitory peptide from the γ-subunit,” Journal of Biological Chemistry, vol. 282, no. 9, pp. 6153–6160, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Leyvraz, R. P. Charles, I. Rubera et al., “The epidermal barrier function is dependent on the serine protease CAP1/Prss8,” Journal of Cell Biology, vol. 170, no. 3, pp. 487–496, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. L.-M. Chen, C. Wang, M. Chen et al., “Prostasin attenuates inducible nitric oxide synthase expression in lipopolysaccharide-induced urinary bladder inflammation,” American Journal of Physiology, vol. 291, no. 3, pp. F567–F577, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Narikiyo, K. Kitamura, M. Adachi et al., “Regulation of prostasin by aldosterone in the kidney,” Journal of Clinical Investigation, vol. 109, no. 3, pp. 401–408, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. L.-M. Chen and K. X. Chai, “Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter dna methylation,” International Journal of Cancer, vol. 97, no. 3, pp. 323–329, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. L.-M. Chen, G. Byron Hodge, L. A. Guarda, J. L. Welch, N. M. Greenberg, and K. X. Chai, “Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancer,” Prostate, vol. 48, no. 2, pp. 93–103, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. K. W. Rickert, P. Kelley, N. J. Byrne et al., “Structure of human prostasin, a target for the regulation of hypertension,” Journal of Biological Chemistry, vol. 283, no. 50, pp. 34864–34872, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. J.-D. Vassalli, J. Huarte, D. Bosco et al., “Protease-nexin I as an androgen-dependent secretory product of the murine seminal vesicle,” EMBO Journal, vol. 12, no. 5, pp. 1871–1878, 1993. View at Google Scholar · View at Scopus
  22. L.-M. Chen, X. Zhang, and K. X. Chai, “Regulation of prostasin expression and function in the prostate,” Prostate, vol. 59, no. 1, pp. 1–12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. D. J. Knauer, J. A. Thompson, and D. D. Cunningham, “Protease nexins: cell-secreted proteins that mediate the binding, internalization, and degradation of regulatory serine proteases,” Journal of Cellular Physiology, vol. 117, no. 3, pp. 385–396, 1983. View at Google Scholar · View at Scopus
  24. B. Fan, T. D. Wu, W. Li, and D. Kirchhofer, “Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin,” Journal of Biological Chemistry, vol. 280, no. 41, pp. 34513–34520, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. Y.-W. Chen, J.-K. Wang, F.-P. Chou et al., “Regulation of the matriptase-prostasin cell surface proteolytic cascade by hepatocyte growth factor activator inhibitor-1 during epidermal differentiation,” Journal of Biological Chemistry, vol. 285, no. 41, pp. 31755–31762, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Maekawa, Y. Kakizoe, T. Miyoshi et al., “Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension,” Journal of Hypertension, vol. 27, no. 1, pp. 181–189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Coote, H. C. Atherton-Watson, R. Sugar et al., “Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease,” Journal of Pharmacology and Experimental Therapeutics, vol. 329, no. 2, pp. 764–774, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Kirchhofer, M. Peek, W. Li et al., “Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1,” Journal of Biological Chemistry, vol. 278, no. 38, pp. 36341–36349, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Netzel-Arnett, B. M. Currie, R. Szabo et al., “Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation,” Journal of Biological Chemistry, vol. 281, no. 44, pp. 32941–32945, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. M. D. Oberst, L.-Y. L. Chen, K.-I. Kiyomiya et al., “HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease,” American Journal of Physiology, vol. 289, no. 2, pp. C462–C470, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. M. D. Oberst, C. A. Williams, R. B. Dickson, M. D. Johnson, and C.-Y. Lin, “The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor,” Journal of Biological Chemistry, vol. 278, no. 29, pp. 26773–26779, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. K. List, R. Szabo, P. W. Wertz et al., “Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1,” Journal of Cell Biology, vol. 163, no. 4, pp. 901–910, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. K. List, C. C. Haudenschild, R. Szabo et al., “Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis,” Oncogene, vol. 21, no. 23, pp. 3765–3779, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Tarran, L. Trout, S. H. Donaldson, and R. C. Boucher, “Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia,” Journal of General Physiology, vol. 127, no. 5, pp. 591–604, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Wang, J. Chao, and L. Chao, “Adenovirus-mediated human prostasin gene delivery is linked to increased aldosterone production and hypertension in rats,” American Journal of Physiology, vol. 284, no. 4, pp. R1031–R1036, 2003. View at Google Scholar · View at Scopus
  36. R. S. Herbst, “Review of epidermal growth factor receptor biology,” International Journal of Radiation Oncology Biology Physics, vol. 59, supplement 2, pp. 21–26, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. Y.-Y. Fu, W.-L. Gao, M. Chen, K. X. Chai, Y.-L. Wang, and L.-M. Chen, “Prostasin regulates human placental trophoblast cell proliferation via the epidermal growth factor receptor signaling pathway,” Human Reproduction, vol. 25, no. 3, pp. 623–632, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Takahashi, S. Suzuki, S. Inaguma et al., “Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers,” Prostate, vol. 54, no. 3, pp. 187–193, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Tvorogov and G. Carpenter, “EGF-dependent association of phospholipase C-γ1 with c-Cbl,” Experimental Cell Research, vol. 277, no. 1, pp. 86–94, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. C. López-Otín and L. M. Matrisian, “Emerging roles of proteases in tumour suppression,” Nature Reviews Cancer, vol. 7, no. 10, pp. 800–808, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Chen, L.-M. Chen, C.-Y. Lin, and K. X. Chai, “The epidermal growth factor receptor (EGFR) is proteolytically modified by the Matriptase-Prostasin serine protease cascade in cultured epithelial cells,” Biochimica et Biophysica Acta, vol. 1783, no. 5, pp. 896–903, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Chen, Y.-Y. Fu, C.-Y. Lin, L.-M. Chen, and K. X. Chai, “Prostasin induces protease-dependent and independent molecular changes in the human prostate carcinoma cell line PC-3,” Biochimica et Biophysica Acta, vol. 1773, no. 7, pp. 1133–1140, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. M. M. Myerburg, E. E. McKenna, C. J. Luke, R. A. Frizzell, T. R. Kleyman, and J. M. Pilewski, “Prostasin expression is regulated by airway surface liquid volume and is increased in cystic fibrosis,” American Journal of Physiology, vol. 294, no. 5, pp. L932–L941, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. Z. Tong, B. Illek, V. J. Bhagwandin, G. M. Verghese, and G. H. Caughey, “Prostasin, a membrane-anchored serine peptidase, regulates sodium currents in JME/CF15 cells, a cystic fibrosis airway epithelial cell line,” American Journal of Physiology, vol. 287, no. 5, pp. L928–L935, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Adachi, K. Kitamura, T. Miyoshi et al., “Activation of epithelial sodium channels by prostasin in Xenopus oocytes,” Journal of the American Society of Nephrology, vol. 12, no. 6, pp. 1114–1121, 2001. View at Google Scholar · View at Scopus
  46. K. Gormley, Y. Dong, and G. A. Sagnella, “Regulation of the epithelial sodium channel by accessory proteins,” Biochemical Journal, vol. 371, no. 1, pp. 1–14, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Persu, P. Barbry, F. Bassilana et al., “Genetic analysis of the β subunit of the epithelial Na+ channel in essential hypertension,” Hypertension, vol. 32, no. 1, pp. 129–137, 1998. View at Google Scholar · View at Scopus
  48. A. Persu, S. Coscoy, A.-M. Houot, P. Corvol, P. Barbry, and X. Jeunemaitre, “Polymorphisms of the γ subunit of the epithelial Na+ channel in essential hypertension,” Journal of Hypertension, vol. 17, no. 5, pp. 639–645, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. W. T. Ambrosius, L. J. Bloem, L. Zhou et al., “Genetic variants in the epithelial sodium channel in relation to aldosterone and potassium excretion and risk for hypertension,” Hypertension, vol. 34, no. 4 I, pp. 631–637, 1999. View at Google Scholar · View at Scopus
  50. J. M. Hollier, D. F. Martin, D. M. Bell et al., “Epithelial sodium channel allele T594M is not associated with blood pressure or blood pressure response to amiloride,” Hypertension, vol. 47, no. 3, pp. 428–433, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Garty and L. G. Palmer, “Epithelial sodium channels: function, structure and regulation,” Physiological Reviews, vol. 77, no. 2, pp. 359–396, 1997. View at Google Scholar · View at Scopus
  52. S. H. Donaldson and R. C. Boucher, “Sodium channels and cystic fibrosis,” Chest, vol. 132, no. 5, pp. 1631–1636, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. M. M. Myerburg, M. B. Butterworth, E. E. McKenna et al., “Airway surface liquid volume regulates ENaC by altering the serine protease-protease inhibitor balance: a mechanism for sodium hyperabsorption in cystic fibrosis,” Journal of Biological Chemistry, vol. 281, no. 38, pp. 27942–27949, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. T. Ko, Y. Kakizoe, N. Wakida et al., “Regulation of adrenal aldosterone production by serine protease prostasin,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 793843, 9 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. O. Olivieri, A. Castagna, P. Guarini et al., “Urinary prostasin: a candidate marker of epithelial sodium channel activation in humans,” Hypertension, vol. 46, no. 4, pp. 683–688, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Koda, N. Wakida, K. Toriyama et al., “Urinary prostasin in humans: relationships among prostasin, aldosterone and epithelial sodium channel activity,” Hypertension Research, vol. 32, no. 4, pp. 276–281, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Barr, S. Thomson, E. Buck et al., “Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions,” Clinical and Experimental Metastasis, vol. 25, no. 6, pp. 685–693, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. L.-M. Chen, N. J. Verity, and K. X. Chai, “Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT),” BMC Cancer, vol. 9, article 377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Jones, A. Mackay, A. Grigoriadis et al., “Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of Novel Prognostic Markers for breast cancer,” Cancer Research, vol. 64, no. 9, pp. 3037–3045, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. K. Sakashita, K. Mimori, F. Tanaka et al., “Clinical significance of low expression of Prostasin mRNA in human gastric cancer,” Journal of Surgical Oncology, vol. 98, no. 7, pp. 559–564, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. C. Bergum, G. Zoratti, J. Boerner, and K. List, “Strong expression association between matriptase and its substrate prostasin in breast cancer,” Journal of Cellular Physiology, vol. 227, no. 4, pp. 1604–1609, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Selzer-Plon, J. Bornholdt, S. Friis et al., “Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis,” BMC Cancer, vol. 9, article 201, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Cavalieri, P. Dolara, E. Mini et al., “Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer,” Oncology Research, vol. 16, no. 11, pp. 535–548, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. S. C. Mok, J. Chao, S. Skates et al., “Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology,” Journal of the National Cancer Institute, vol. 93, no. 19, pp. 1458–1464, 2001. View at Google Scholar · View at Scopus
  65. F. P. Costa, E. L. Batista Jr., A. Zelmanowicz et al., “Prostasin, a potential tumor marker in ovarian cancer—A Pilot Study,” Clinics, vol. 64, no. 7, pp. 641–644, 2009. View at Publisher · View at Google Scholar · View at Scopus